{"transactions":[{"id":775574,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-18T17:39:18.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":4848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock unit (\"RSU\") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date."}],"balance_after":4848,"derivative":{"underlying":"Common Stock","underlying_shares":4848},"source":{"system":"sec-edgar","filing":"0001110753-26-000006","document":"wk-form4_1779140353.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000111075326000006/wk-form4_1779140353.xml","form_type":"4"}},{"id":9890,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"NQ Stock Option (Right to Buy)","published_at":"2026-05-14T22:49:27.000Z","date":"2026-05-13","kind":"exercise","planned":false,"acquired":false,"shares":4532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option became exercisable in four equal annual installments beginning on January 25, 2020."}],"balance_after":0,"derivative":{"exercise_price":104.41,"expiration_date":"2029-01-25","underlying":"Common Stock","underlying_shares":4532},"source":{"system":"sec-edgar","filing":"0000097476-26-000137","document":"wk-form4_1778798964.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/97476/000009747626000137/wk-form4_1778798964.xml","form_type":"4"}},{"id":9889,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"NQ Stock Option (Right to Buy)","published_at":"2026-05-14T22:49:27.000Z","date":"2026-05-13","kind":"exercise","planned":false,"acquired":false,"shares":4306,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option became exercisable in four equal annual installments beginning on January 25, 2019."}],"balance_after":0,"derivative":{"exercise_price":110.15,"expiration_date":"2028-01-25","underlying":"Common Stock","underlying_shares":4306},"source":{"system":"sec-edgar","filing":"0000097476-26-000137","document":"wk-form4_1778798964.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/97476/000009747626000137/wk-form4_1778798964.xml","form_type":"4"}},{"id":9888,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T22:49:27.000Z","date":"2026-05-13","kind":"sale","planned":false,"acquired":false,"shares":445,"price":307.0433,"value":136634.2685,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $306.94 to $307.24. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price."}],"balance_after":37626,"source":{"system":"sec-edgar","filing":"0000097476-26-000137","document":"wk-form4_1778798964.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/97476/000009747626000137/wk-form4_1778798964.xml","form_type":"4"}},{"id":9887,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T22:49:27.000Z","date":"2026-05-13","kind":"sale","planned":false,"acquired":false,"shares":8393,"price":306.3737,"value":2571394.4641,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $305.91 to $306.89. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price."}],"balance_after":38071,"source":{"system":"sec-edgar","filing":"0000097476-26-000137","document":"wk-form4_1778798964.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/97476/000009747626000137/wk-form4_1778798964.xml","form_type":"4"}},{"id":9886,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T22:49:27.000Z","date":"2026-05-13","kind":"exercise","planned":false,"acquired":true,"shares":4532,"price":104.41,"value":473186.12,"ownership":{"direct":true},"balance_after":46464,"source":{"system":"sec-edgar","filing":"0000097476-26-000137","document":"wk-form4_1778798964.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/97476/000009747626000137/wk-form4_1778798964.xml","form_type":"4"}},{"id":9885,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T22:49:27.000Z","date":"2026-05-13","kind":"exercise","planned":false,"acquired":true,"shares":4306,"price":110.15,"value":474305.9,"ownership":{"direct":true},"balance_after":41932,"source":{"system":"sec-edgar","filing":"0000097476-26-000137","document":"wk-form4_1778798964.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/97476/000009747626000137/wk-form4_1778798964.xml","form_type":"4"}},{"id":795987,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-01T20:26:20.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":false,"shares":4916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock unit (\"RSU\") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs are fully vested."}],"balance_after":0,"derivative":{"expiration_date":"2035-04-30","underlying":"Common Stock","underlying_shares":4916},"source":{"system":"sec-edgar","filing":"0001110753-26-000004","document":"wk-form4_1777667174.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000111075326000004/wk-form4_1777667174.xml","form_type":"4"}},{"id":795986,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-01T20:26:20.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":4916,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16400,"source":{"system":"sec-edgar","filing":"0001110753-26-000004","document":"wk-form4_1777667174.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000111075326000004/wk-form4_1777667174.xml","form_type":"4"}},{"id":825555,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-03-30T23:44:33.000Z","date":"2026-03-27","kind":"exercise","planned":false,"acquired":false,"shares":6336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock unit (\"RSU\") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs are fully vested."}],"balance_after":0,"derivative":{"expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":6336},"source":{"system":"sec-edgar","filing":"0001110753-26-000002","document":"wk-form4_1774914270.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000111075326000002/wk-form4_1774914270.xml","form_type":"4"}},{"id":825554,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-30T23:44:33.000Z","date":"2026-03-27","kind":"exercise","planned":false,"acquired":true,"shares":6336,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11484,"source":{"system":"sec-edgar","filing":"0001110753-26-000002","document":"wk-form4_1774914270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000111075326000002/wk-form4_1774914270.xml","form_type":"4"}},{"id":14960,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"NQ Stock Option (Right to Buy)","published_at":"2026-02-02T21:24:09.000Z","date":"2026-01-29","kind":"grant","planned":false,"acquired":true,"shares":1860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option becomes exercisable in four equal installments beginning on January 29, 2027."}],"balance_after":1860,"derivative":{"exercise_price":218.97,"expiration_date":"2036-01-29","underlying":"Common Stock","underlying_shares":1860},"source":{"system":"sec-edgar","filing":"0000097476-26-000044","document":"wk-form4_1770067446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/97476/000009747626000044/wk-form4_1770067446.xml","form_type":"4"}},{"id":14959,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-02T21:24:09.000Z","date":"2026-01-29","kind":"grant","planned":false,"acquired":true,"shares":525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan."}],"balance_after":37626,"source":{"system":"sec-edgar","filing":"0000097476-26-000044","document":"wk-form4_1770067446.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/97476/000009747626000044/wk-form4_1770067446.xml","form_type":"4"}},{"id":1000671,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chair"}}],"security":"Common Stock","published_at":"2025-11-13T21:05:10.000Z","date":"2025-11-12","kind":"purchase","planned":false,"acquired":true,"shares":65400,"price":7.6721,"value":501755.34,"ownership":{"direct":false,"nature":"IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price of $7.6721. These shares were purchased in multiple transactions at prices ranging from $7.6630 to $7.6899, inclusive. The reporting person undertakes to provide to Organon & Co. (\"Organon\"), any security holder of Organon, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":77869,"source":{"system":"sec-edgar","filing":"0001628280-25-052004","document":"wk-form4_1763067905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000162828025052004/wk-form4_1763067905.xml","form_type":"4"}},{"id":1110230,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock","published_at":"2025-06-16T21:17:16.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":23904.382,"price":10.04,"value":239999.99528,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each phantom stock unit is an economic equivalent of one share of Organon & Co. (\"Organon\") common stock, or 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the \"Plan\") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the \"Plan\") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Holdings include phantom stock units acquired in dividend reinvestment transactions on June 13, 2024, September 12, 2024, December 12, 2024, March 13, 2025 and June 12, 2025."}],"balance_after":74029.769,"derivative":{"underlying":"Common Stock","underlying_shares":23904.382},"source":{"system":"sec-edgar","filing":"0001821825-25-000041","document":"wk-form4_1750108628.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000182182525000041/wk-form4_1750108628.xml","form_type":"4"}},{"id":1147859,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-15T20:23:40.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":false,"shares":5148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs fully vested on May 13, 2025."}],"balance_after":0,"derivative":{"expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":5148},"source":{"system":"sec-edgar","filing":"0001628280-25-025969","document":"wk-form4_1747340612.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000162828025025969/wk-form4_1747340612.xml","form_type":"4"}},{"id":1147858,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-15T20:23:40.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":true,"shares":5148,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5148,"source":{"system":"sec-edgar","filing":"0001628280-25-025969","document":"wk-form4_1747340612.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000162828025025969/wk-form4_1747340612.xml","form_type":"4"}},{"id":1147857,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-15T20:09:09.000Z","date":"2025-05-14","kind":"purchase","planned":false,"acquired":true,"shares":12469,"price":8.0673,"value":100591.1637,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price (which was $8.06727998, rounded due to character limitations in the price field). These shares were purchased in multiple transactions at prices ranging from $8.059 to $8.07, inclusive. The reporting person undertakes to provide to Organon & Co. (\"Organon\"), any security holder of Organon, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":12469,"source":{"system":"sec-edgar","filing":"0001821825-25-000037","document":"wk-form4_1747339741.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000182182525000037/wk-form4_1747339741.xml","form_type":"4"}},{"id":1161534,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-02T20:34:40.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":4916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall fully vest on April 30, 2026, subject to continued service through the vesting date."}],"balance_after":4916,"derivative":{"expiration_date":"2035-04-30","underlying":"Common Stock","underlying_shares":4916},"source":{"system":"sec-edgar","filing":"0001628280-25-021885","document":"wk-form4_1746218073.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000162828025021885/wk-form4_1746218073.xml","form_type":"4"}},{"id":29669,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"NQ Stock Option (Right to Buy)","published_at":"2025-01-29T21:43:33.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":2551,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option becomes exercisable in four equal installments beginning on January 27, 2026."}],"balance_after":2551,"derivative":{"exercise_price":187.03,"expiration_date":"2035-01-27","underlying":"Common Stock","underlying_shares":2551},"source":{"system":"sec-edgar","filing":"0001127602-25-002263","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760225002263/form4.xml","form_type":"4"}},{"id":29668,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-01-29T21:43:33.000Z","date":"2025-01-27","kind":"grant","planned":false,"acquired":true,"shares":614,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan."}],"balance_after":37101,"source":{"system":"sec-edgar","filing":"0001127602-25-002263","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760225002263/form4.xml","form_type":"4"}},{"id":1311477,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-06T21:19:16.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8000,"derivative":{"exercise_price":16.93,"exercise_date":"2026-01-02","expiration_date":"2035-01-01","underlying":"Common  Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001453687-25-000016","document":"wk-form4_1736198350.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000145368725000016/wk-form4_1736198350.xml","form_type":"4"}},{"id":1311476,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common  Stock","published_at":"2025-01-06T21:19:16.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On April 4, 2024, the issuer effected a 1-for-30 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":15629,"source":{"system":"sec-edgar","filing":"0001453687-25-000016","document":"wk-form4_1736198350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000145368725000016/wk-form4_1736198350.xml","form_type":"4"}},{"id":1483881,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock","published_at":"2024-06-11T19:17:18.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":9638.554,"price":20.75,"value":199999.9955,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each phantom stock unit is an economic equivalent of one share of Organon & Co. (\"Organon\") common stock, or 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the \"Plan\") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the \"Plan\") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Holdings include phantom stock acquired in dividend reinvestment transactions on June 15, 2023, September 14, 2023, December 14, 2023 and March 14, 2024."}],"balance_after":47059.859,"derivative":{"underlying":"Common Stock","underlying_shares":9638.554},"source":{"system":"sec-edgar","filing":"0001821825-24-000076","document":"wk-form4_1718133431.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000182182524000076/wk-form4_1718133431.xml","form_type":"4"}},{"id":1516286,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-05-15T20:52:22.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":6336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock unit (\"RSU\") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall fully vest on March 27, 2026, subject to continued service through the vesting date."}],"balance_after":11484,"derivative":{"expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":6336},"source":{"system":"sec-edgar","filing":"0001127602-24-015491","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000112760224015491/form4.xml","form_type":"4"}},{"id":1516285,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-05-15T20:52:22.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":5148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock unit (\"RSU\") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall fully vest on May 13, 2025, subject to continued service through the vesting date."}],"balance_after":5148,"derivative":{"expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":5148},"source":{"system":"sec-edgar","filing":"0001127602-24-015491","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000112760224015491/form4.xml","form_type":"4"}},{"id":47916,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"NQ Stock Option (Right to Buy)","published_at":"2024-01-29T21:37:59.000Z","date":"2024-01-25","kind":"grant","planned":false,"acquired":true,"shares":3066,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option becomes exercisable in four equal annual installments beginning on January 25, 2025."}],"balance_after":3066,"derivative":{"exercise_price":167.42,"expiration_date":"2034-01-25","underlying":"Common Stock","underlying_shares":3066},"source":{"system":"sec-edgar","filing":"0001127602-24-002436","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760224002436/form4.xml","form_type":"4"}},{"id":47915,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-29T21:37:59.000Z","date":"2024-01-25","kind":"grant","planned":false,"acquired":true,"shares":686,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan."}],"balance_after":36487,"source":{"system":"sec-edgar","filing":"0001127602-24-002436","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760224002436/form4.xml","form_type":"4"}},{"id":1688622,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T22:05:15.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":248000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award will vest in 36 equal monthly installments, so that it shall be fully vested on January 2, 2027."}],"balance_after":248000,"derivative":{"exercise_price":0.6552,"expiration_date":"2034-01-01","underlying":"Common  Stock","underlying_shares":248000},"source":{"system":"sec-edgar","filing":"0001453687-24-000019","document":"wk-form4_1704405888.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000145368724000019/wk-form4_1704405888.xml","form_type":"4"}},{"id":1688621,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T22:05:15.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":178000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in three equal annual installments so that the underlying shares will be fully vested on January 2, 2027."}],"balance_after":390881,"source":{"system":"sec-edgar","filing":"0001453687-24-000019","document":"wk-form4_1704405888.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000145368724000019/wk-form4_1704405888.xml","form_type":"4"}},{"id":1741076,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-15T22:14:52.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":107500,"price":0.93,"value":99975.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, which provided for vesting in full on January 2, 2024, was canceled in the Merger in exchange for a cash payment of $99,975, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger."}],"balance_after":0,"derivative":{"exercise_price":1.13,"expiration_date":"2033-01-01","underlying":"Common Stock","underlying_shares":107500},"source":{"system":"sec-edgar","filing":"0001453687-23-000081","document":"wk-form4_1700086481.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000145368723000081/wk-form4_1700086481.xml","form_type":"4"}},{"id":1741075,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-15T22:14:52.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This option, which provided for vesting in full on January 3, 2023, was canceled in the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, which provided for vesting in full on January 3, 2023, was canceled in the Merger."}],"balance_after":0,"derivative":{"exercise_price":3.31,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001453687-23-000081","document":"wk-form4_1700086481.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000145368723000081/wk-form4_1700086481.xml","form_type":"4"}},{"id":1741074,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-15T22:14:52.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This option, which provided for vesting in full on March 30, 2022, was canceled in the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, which provided for vesting in full on March 30, 2022, was canceled in the Merger."}],"balance_after":0,"derivative":{"exercise_price":4.01,"expiration_date":"2031-03-29","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001453687-23-000081","document":"wk-form4_1700086481.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000145368723000081/wk-form4_1700086481.xml","form_type":"4"}},{"id":1741073,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-15T22:14:52.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option, which provided for vesting in full on June 17, 2021, was canceled in the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, which provided for vesting in full on June 17, 2021, was canceled in the Merger."}],"balance_after":0,"derivative":{"exercise_price":3,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001453687-23-000081","document":"wk-form4_1700086481.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000145368723000081/wk-form4_1700086481.xml","form_type":"4"}},{"id":1741072,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-15T22:14:52.000Z","date":"2023-11-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"price":0.74,"value":14800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, which provided for vesting in thirty-six (36) substantially equal monthly installments over three years following the date of grant on November 20, 2019, was canceled in the merger (the \"Merger\") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc. in exchange for a cash payment of $14,800, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger."}],"balance_after":0,"derivative":{"exercise_price":1.32,"expiration_date":"2029-11-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001453687-23-000081","document":"wk-form4_1700086481.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000145368723000081/wk-form4_1700086481.xml","form_type":"4"}},{"id":54076,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"NQ Stock Option (Right to Buy)","published_at":"2023-08-03T17:06:34.000Z","date":"2023-07-31","kind":"exercise","planned":false,"acquired":false,"shares":6065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option became exercisable in four equal annual installments beginning on January 26, 2018."}],"balance_after":0,"derivative":{"exercise_price":79.26,"expiration_date":"2027-01-26","underlying":"Common Stock","underlying_shares":6065},"source":{"system":"sec-edgar","filing":"0001127602-23-021922","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760223021922/form4.xml","form_type":"4"}},{"id":54075,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"NQ Stock Option (Right to Buy)","published_at":"2023-08-03T17:06:34.000Z","date":"2023-07-31","kind":"exercise","planned":false,"acquired":false,"shares":9990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option became exercisable in four equal annual installments beginning on January 29, 2017."}],"balance_after":0,"derivative":{"exercise_price":52.93,"expiration_date":"2026-01-29","underlying":"Common Stock","underlying_shares":9990},"source":{"system":"sec-edgar","filing":"0001127602-23-021922","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760223021922/form4.xml","form_type":"4"}},{"id":54074,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-03T17:06:34.000Z","date":"2023-07-31","kind":"sale","planned":false,"acquired":false,"shares":16055,"price":180.04,"value":2890542.2,"ownership":{"direct":true},"balance_after":35801,"source":{"system":"sec-edgar","filing":"0001127602-23-021922","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760223021922/form4.xml","form_type":"4"}},{"id":54073,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-03T17:06:34.000Z","date":"2023-07-31","kind":"exercise","planned":false,"acquired":true,"shares":6065,"price":79.26,"value":480711.9,"ownership":{"direct":true},"balance_after":51856,"source":{"system":"sec-edgar","filing":"0001127602-23-021922","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760223021922/form4.xml","form_type":"4"}},{"id":54072,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-03T17:06:34.000Z","date":"2023-07-31","kind":"exercise","planned":false,"acquired":true,"shares":9990,"price":52.93,"value":528770.7,"ownership":{"direct":true},"balance_after":45791,"source":{"system":"sec-edgar","filing":"0001127602-23-021922","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760223021922/form4.xml","form_type":"4"}},{"id":1857558,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock","published_at":"2023-06-13T20:46:39.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":10086,"price":19.83,"value":200005.38,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each phantom stock unit is an economic equivalent of one share of Organon & Co. (\"Organon\") common stock, or 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the \"Plan\") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the \"Plan\") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Holdings include phantom stock acquired in dividend reinvestment transactions on June 16, 2022, September 15, 2022, December 15, 2022 and March 16, 2023."}],"balance_after":35232,"derivative":{"underlying":"Common Stock","underlying_shares":10086},"source":{"system":"sec-edgar","filing":"0001209191-23-036752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000120919123036752/doc4.xml","form_type":"4"}},{"id":59851,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"NQ Stock Option (Right to Buy)","published_at":"2023-01-30T21:55:51.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":2159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in four equal annual installments beginning on January 26, 2024."}],"balance_after":2159,"derivative":{"exercise_price":174.1,"expiration_date":"2033-01-26","underlying":"Common Stock","underlying_shares":2159},"source":{"system":"sec-edgar","filing":"0001127602-23-002679","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760223002679/form4.xml","form_type":"4"}},{"id":59850,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-01-30T21:55:51.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan."}],"balance_after":35801,"source":{"system":"sec-edgar","filing":"0001127602-23-002679","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760223002679/form4.xml","form_type":"4"}},{"id":2069074,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-04T22:03:06.000Z","date":"2023-01-02","kind":"grant","acquired":true,"shares":107500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Common Stock underlying this award will vest in full on January 2, 2024."}],"balance_after":107500,"derivative":{"exercise_price":1.13,"expiration_date":"2033-01-01","underlying":"Common Stock","underlying_shares":107500},"source":{"system":"sec-edgar","filing":"0001453687-23-000021","document":"wf-form4_167286975633037.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000145368723000021/wf-form4_167286975633037.xml","form_type":"4"}},{"id":2120631,"issuer":{"id":3014,"kind":"organization","name":"CARDINAL HEALTH INC"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-11-10T21:25:22.000Z","date":"2022-11-09","kind":"grant","acquired":true,"shares":2308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted share units that will vest on November 9, 2023, except if the 2023 Annual Meeting of Shareholders is prior to November 9, 2023, then the restricted share units will vest on the date of the 2023 Annual Meeting of Shareholders."}],"balance_after":41631,"source":{"system":"sec-edgar","filing":"0000721371-22-000156","document":"wf-form4_166811550524579.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/721371/000072137122000156/wf-form4_166811550524579.xml","form_type":"4"}},{"id":2231738,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-15T20:16:11.000Z","date":"2022-06-13","kind":"purchase","acquired":true,"shares":130000,"price":1.1523,"value":149799.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $1.13 to $1.17. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":212881,"source":{"system":"sec-edgar","filing":"0001453687-22-000104","document":"wf-form4_165532415494758.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000145368722000104/wf-form4_165532415494758.xml","form_type":"4"}},{"id":2232977,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock","published_at":"2022-06-14T23:31:10.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":5640,"price":35.46,"value":199994.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each phantom stock unit is an economic equivalent of one share of Organon & Co. (\"Organon\") common stock, or 1-for-1."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the \"Plan\") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the \"Plan\") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Holdings include phantom stock acquired in dividend reinvestment transactions on September 13, 2021, December 16, 2021 and March 17, 2022."}],"balance_after":24187,"derivative":{"underlying":"Common Stock","underlying_shares":5640},"source":{"system":"sec-edgar","filing":"0001104659-22-071133","document":"tm2218336-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000110465922071133/tm2218336-1_4seq1.xml","form_type":"4"}},{"id":72469,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"NQ Stock Option (Right to Buy)","published_at":"2022-01-31T22:29:50.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":2512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in four equal annual installments beginning on January 27, 2023."}],"balance_after":2512,"derivative":{"exercise_price":174.81,"expiration_date":"2032-01-27","underlying":"Common Stock","underlying_shares":2512},"source":{"system":"sec-edgar","filing":"0001127602-22-002570","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760222002570/form4.xml","form_type":"4"}},{"id":72468,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-01-31T22:29:50.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":572,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan."}],"balance_after":35227,"source":{"system":"sec-edgar","filing":"0001127602-22-002570","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760222002570/form4.xml","form_type":"4"}},{"id":2444901,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-05T21:32:33.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Common Stock underlying this award will vest in full on January 3, 2023."}],"balance_after":60000,"derivative":{"exercise_price":3.31,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001453687-22-000017","document":"wf-form4_164141832752094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000145368722000017/wf-form4_164141832752094.xml","form_type":"4"}},{"id":2484110,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-06T21:25:07.000Z","date":"2021-12-03","kind":"purchase","acquired":true,"shares":17200,"price":2.9456,"value":50664.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $2.93 to $2.95. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":82881,"source":{"system":"sec-edgar","filing":"0001453687-21-000162","document":"wf-form4_163882589265567.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000145368721000162/wf-form4_163882589265567.xml","form_type":"4"}},{"id":2513941,"issuer":{"id":3014,"kind":"organization","name":"CARDINAL HEALTH INC"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-11-15T13:09:16.000Z","date":"2021-11-11","kind":"grant","acquired":true,"shares":3709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted share units that will vest on November 11, 2022, except if the 2022 Annual Meeting of Shareholders is prior to November 11, 2022, then the restricted share units will vest on the date of the 2022 Annual Meeting of Shareholders."}],"balance_after":39323,"source":{"system":"sec-edgar","filing":"0000721371-21-000132","document":"wf-form4_163698174117116.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/721371/000072137121000132/wf-form4_163698174117116.xml","form_type":"4"}},{"id":2678013,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock","published_at":"2021-06-09T00:44:13.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":18079,"price":36.05,"value":651747.95,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"1-for-1"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of (i) a one-time grant of 14,856 phantom units awarded in connection with the separation of Organon & Co. (\"Organon\") from Merck & Co., Inc. (the \"Separation\"), which units will vest in full on the earlier of the one-year anniversary of the Separation or Organon's first annual shareholders meeting after the Separation, and (ii) a pro-rata portion of the annual equity retainer in the form of 3,223 phantom units, which units are fully vested. Phantom units are granted under the Organon Non-Employee Director Savings Plan and are payable in cash upon settlement no sooner than one year after service as a director ceases."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Consists of (i) a one-time grant of 14,856 phantom units awarded in connection with the separation of Organon & Co. (\"Organon\") from Merck & Co., Inc. (the \"Separation\"), which units will vest in full on the earlier of the one-year anniversary of the Separation or Organon's first annual shareholders meeting after the Separation, and (ii) a pro-rata portion of the annual equity retainer in the form of 3,223 phantom units, which units are fully vested. Phantom units are granted under the Organon Non-Employee Director Savings Plan and are payable in cash upon settlement no sooner than one year after service as a director ceases."}],"balance_after":18079,"derivative":{"underlying":"Common Stock","underlying_shares":18079},"source":{"system":"sec-edgar","filing":"0000899243-21-022688","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000089924321022688/doc4.xml","form_type":"4"}},{"id":2764796,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-01T22:30:25.000Z","date":"2021-03-30","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on March 30, 2022."}],"balance_after":60000,"derivative":{"exercise_price":4.01,"expiration_date":"2031-03-29","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001453687-21-000045","document":"wf-form4_161731615580945.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000145368721000045/wf-form4_161731615580945.xml","form_type":"4"}},{"id":94577,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"NQ Stock Option (Right to Buy)","published_at":"2021-02-01T23:41:43.000Z","date":"2021-01-28","kind":"grant","acquired":true,"shares":2457,"price":169.23,"value":415798.11,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in four equal annual installments beginning on January 28, 2022."}],"balance_after":2457,"derivative":{"exercise_price":169.23,"expiration_date":"2031-01-28","underlying":"Common Stock","underlying_shares":2457},"source":{"system":"sec-edgar","filing":"0001127602-21-003339","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760221003339/form4.xml","form_type":"4"}},{"id":94576,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-02-01T23:41:43.000Z","date":"2021-01-28","kind":"grant","acquired":true,"shares":590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan."}],"balance_after":34655,"source":{"system":"sec-edgar","filing":"0001127602-21-003339","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760221003339/form4.xml","form_type":"4"}},{"id":2987531,"issuer":{"id":3014,"kind":"organization","name":"CARDINAL HEALTH INC"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-11-10T21:33:13.000Z","date":"2020-11-09","kind":"grant","acquired":true,"shares":3339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted share units that will vest on November 9, 2021, except if the 2021 Annual Meeting of Shareholders is prior to November 9, 2021, then the restricted share units will vest on the date of the 2021 Annual Meeting of Shareholders."}],"balance_after":35614,"source":{"system":"sec-edgar","filing":"0000721371-20-000147","document":"wf-form4_160504397837010.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/721371/000072137120000147/wf-form4_160504397837010.xml","form_type":"4"}},{"id":99725,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"NQ Stock Option (Right to Buy)","published_at":"2020-10-27T21:04:18.000Z","date":"2020-10-23","kind":"exercise","acquired":false,"shares":10539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option became exercisable in four equal annual installments beginning on January 28, 2016."}],"balance_after":0,"derivative":{"exercise_price":53.94,"expiration_date":"2025-01-28","underlying":"Common Stock","underlying_shares":10539},"source":{"system":"sec-edgar","filing":"0001127602-20-027576","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760220027576/form4.xml","form_type":"4"}},{"id":99724,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"NQ Stock Option (Right to Buy)","published_at":"2020-10-27T21:04:18.000Z","date":"2020-10-23","kind":"exercise","acquired":false,"shares":12299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option became exercisable in four equal annual installments beginning on January 23, 2015."}],"balance_after":0,"derivative":{"exercise_price":44.09,"expiration_date":"2024-01-23","underlying":"Common Stock","underlying_shares":12299},"source":{"system":"sec-edgar","filing":"0001127602-20-027576","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760220027576/form4.xml","form_type":"4"}},{"id":99723,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-10-27T21:04:18.000Z","date":"2020-10-23","kind":"sale","acquired":false,"shares":22838,"price":149.3116,"value":3409978.3208,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in Table 1 is a weighted average sale price.  The sales were at prices ranging from $149.01 to $149.59.   The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price."}],"balance_after":34065,"source":{"system":"sec-edgar","filing":"0001127602-20-027576","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760220027576/form4.xml","form_type":"4"}},{"id":99722,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-10-27T21:04:18.000Z","date":"2020-10-23","kind":"exercise","acquired":true,"shares":10539,"price":53.94,"value":568473.66,"ownership":{"direct":true},"balance_after":56903,"source":{"system":"sec-edgar","filing":"0001127602-20-027576","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760220027576/form4.xml","form_type":"4"}},{"id":99721,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-10-27T21:04:18.000Z","date":"2020-10-23","kind":"exercise","acquired":true,"shares":12299,"price":44.09,"value":542262.91,"ownership":{"direct":true},"balance_after":46364,"source":{"system":"sec-edgar","filing":"0001127602-20-027576","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760220027576/form4.xml","form_type":"4"}},{"id":103081,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"NQ Stock Option (Right to Buy)","published_at":"2020-07-27T22:23:18.000Z","date":"2020-07-24","kind":"exercise","acquired":false,"shares":14749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option became exercisable in four equal annual installments beginning on January 25, 2014."}],"balance_after":0,"derivative":{"exercise_price":32.8,"expiration_date":"2023-01-25","underlying":"Common Stock","underlying_shares":14749},"source":{"system":"sec-edgar","filing":"0001127602-20-022134","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760220022134/form4.xml","form_type":"4"}},{"id":103080,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"NQ Stock Option (Right to Buy)","published_at":"2020-07-27T22:23:18.000Z","date":"2020-07-24","kind":"exercise","acquired":false,"shares":12156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option became exercisable in four equal annual installments beginning on January 26, 2013."}],"balance_after":0,"derivative":{"exercise_price":32.36,"expiration_date":"2022-01-26","underlying":"Common Stock","underlying_shares":12156},"source":{"system":"sec-edgar","filing":"0001127602-20-022134","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760220022134/form4.xml","form_type":"4"}},{"id":103079,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-07-27T22:23:18.000Z","date":"2020-07-24","kind":"sale","acquired":false,"shares":26905,"price":130,"value":3497650.0,"ownership":{"direct":true},"balance_after":34065,"source":{"system":"sec-edgar","filing":"0001127602-20-022134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760220022134/form4.xml","form_type":"4"}},{"id":103078,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-07-27T22:23:18.000Z","date":"2020-07-24","kind":"exercise","acquired":true,"shares":14749,"price":32.8,"value":483767.2,"ownership":{"direct":true},"balance_after":60970,"source":{"system":"sec-edgar","filing":"0001127602-20-022134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760220022134/form4.xml","form_type":"4"}},{"id":103077,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-07-27T22:23:18.000Z","date":"2020-07-24","kind":"exercise","acquired":true,"shares":12156,"price":32.36,"value":393368.16,"ownership":{"direct":true},"balance_after":46221,"source":{"system":"sec-edgar","filing":"0001127602-20-022134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760220022134/form4.xml","form_type":"4"}},{"id":3102226,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-23T20:46:43.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 19, 2021 or the day immediately prior to the company's 2021 annual meeting of stockholders."}],"balance_after":30000,"derivative":{"exercise_price":3,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001453687-20-000076","document":"wf-form4_159294518583491.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000145368720000076/wf-form4_159294518583491.xml","form_type":"4"}},{"id":108902,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"NQ Stock Option (Right to Buy)","published_at":"2020-01-28T21:17:15.000Z","date":"2020-01-24","kind":"grant","acquired":true,"shares":3911,"price":130.52,"value":510463.72,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in four equal annual installments beginning on January 24, 2021."}],"balance_after":3911,"derivative":{"exercise_price":130.52,"expiration_date":"2030-01-24","underlying":"Common Stock","underlying_shares":3911},"source":{"system":"sec-edgar","filing":"0001127602-20-002494","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760220002494/form4.xml","form_type":"4"}},{"id":108901,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-01-28T21:17:15.000Z","date":"2020-01-24","kind":"grant","acquired":true,"shares":766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of restricted stock units granted under the Texas Instruments 2018 Director Compensation Plan."}],"balance_after":34065,"source":{"system":"sec-edgar","filing":"0001127602-20-002494","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760220002494/form4.xml","form_type":"4"}},{"id":3331489,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants","published_at":"2019-12-26T22:30:14.000Z","date":"2019-12-23","kind":"grant","acquired":true,"shares":32840,"price":0.125,"value":4105.0,"ownership":{"direct":true},"balance_after":32840,"derivative":{"exercise_price":1.46,"exercise_date":"2019-12-23","expiration_date":"2024-12-23","underlying":"Common Stock","underlying_shares":32840},"source":{"system":"sec-edgar","filing":"0001104659-19-076221","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000110465919076221/a4.xml","form_type":"4"}},{"id":3331488,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-26T22:30:14.000Z","date":"2019-12-23","kind":"grant","acquired":true,"shares":65681,"price":1.46,"value":95894.26,"ownership":{"direct":true},"balance_after":65681,"source":{"system":"sec-edgar","filing":"0001104659-19-076221","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000110465919076221/a4.xml","form_type":"4"}},{"id":3361504,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-22T21:17:37.000Z","date":"2019-11-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in thirty-six (36) substantially equal monthly installments over three years following the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":1.32,"expiration_date":"2029-11-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001453687-19-000166","document":"wf-form4_157445744260726.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000145368719000166/wf-form4_157445744260726.xml","form_type":"4"}},{"id":3362024,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-11-22T07:30:46.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Celgene common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1125},"source":{"system":"sec-edgar","filing":"0001415889-19-001368","document":"form4-11222019_071133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001368/form4-11222019_071133.xml","form_type":"4"}},{"id":3362023,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-11-22T07:30:46.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Celgene common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001415889-19-001368","document":"form4-11222019_071133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001368/form4-11222019_071133.xml","form_type":"4"}},{"id":3362022,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-11-22T07:30:46.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":6200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Celgene common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":6200},"source":{"system":"sec-edgar","filing":"0001415889-19-001368","document":"form4-11222019_071133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001368/form4-11222019_071133.xml","form_type":"4"}},{"id":3362021,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-11-22T07:30:46.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":4756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Celgene common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4756},"source":{"system":"sec-edgar","filing":"0001415889-19-001368","document":"form4-11222019_071133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001368/form4-11222019_071133.xml","form_type":"4"}},{"id":3362020,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-11-22T07:30:46.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":1454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Celgene common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1454},"source":{"system":"sec-edgar","filing":"0001415889-19-001368","document":"form4-11222019_071133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001368/form4-11222019_071133.xml","form_type":"4"}},{"id":3362019,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-11-22T07:30:46.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of Celgene common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":900},"source":{"system":"sec-edgar","filing":"0001415889-19-001368","document":"form4-11222019_071133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001368/form4-11222019_071133.xml","form_type":"4"}},{"id":3362018,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:46.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":13266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":77.38,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":13266},"source":{"system":"sec-edgar","filing":"0001415889-19-001368","document":"form4-11222019_071133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001368/form4-11222019_071133.xml","form_type":"4"}},{"id":3362017,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:46.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":121.04,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001415889-19-001368","document":"form4-11222019_071133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001368/form4-11222019_071133.xml","form_type":"4"}},{"id":3362016,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:46.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":99.98,"expiration_date":"2026-06-15","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001415889-19-001368","document":"form4-11222019_071133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001368/form4-11222019_071133.xml","form_type":"4"}},{"id":3362015,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:46.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":112.16,"expiration_date":"2025-06-17","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-19-001368","document":"form4-11222019_071133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001368/form4-11222019_071133.xml","form_type":"4"}},{"id":3362014,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:46.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":20700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":88.5,"expiration_date":"2024-07-01","underlying":"Common Stock","underlying_shares":20700},"source":{"system":"sec-edgar","filing":"0001415889-19-001368","document":"form4-11222019_071133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001368/form4-11222019_071133.xml","form_type":"4"}},{"id":3362013,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:46.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":18600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":59.06,"expiration_date":"2023-06-12","underlying":"Common Stock","underlying_shares":18600},"source":{"system":"sec-edgar","filing":"0001415889-19-001368","document":"form4-11222019_071133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001368/form4-11222019_071133.xml","form_type":"4"}},{"id":3362012,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:46.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":18600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":31.8,"expiration_date":"2022-06-13","underlying":"Common Stock","underlying_shares":18600},"source":{"system":"sec-edgar","filing":"0001415889-19-001368","document":"form4-11222019_071133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001368/form4-11222019_071133.xml","form_type":"4"}},{"id":3362011,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:46.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":18600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":29,"expiration_date":"2021-06-15","underlying":"Common Stock","underlying_shares":18600},"source":{"system":"sec-edgar","filing":"0001415889-19-001368","document":"form4-11222019_071133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001368/form4-11222019_071133.xml","form_type":"4"}},{"id":3362010,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-22T07:30:46.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":39535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition in connection with the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 2, 2019, by and among Celgene Corporation (\"Celgene\"), Bristol-Myers Squibb Company (\"BMS\"), and Burgundy Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of BMS (\"Merger Sub\"), pursuant to which Merger Sub will merge with and into Celgene, with Celgene surviving as a direct wholly owned subsidiary of BMS and upon the effective time of such merger (the \"Effective Time\"), each share of Celgene common stock was converted into the right to receive (i) $50.00 in cash, (ii) one share of BMS common stock, and (iii) one contingent value right (\"CVR\") issued by BMS subject to and in accordance with the CVR agreement, dated November 20, 2019, by and between BMS and the Equiniti Trust Company."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-19-001368","document":"form4-11222019_071133.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001368/form4-11222019_071133.xml","form_type":"4"}},{"id":3373764,"issuer":{"id":3014,"kind":"organization","name":"CARDINAL HEALTH INC"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-11-13T21:21:02.000Z","date":"2019-11-12","kind":"grant","acquired":true,"shares":3424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted share units that will vest on November 12, 2020, except if the 2020 Annual Meeting of Shareholders is prior to November 12, 2020, then the restricted share units will vest on the date of the 2020 Annual Meeting of Shareholders."}],"balance_after":32275,"source":{"system":"sec-edgar","filing":"0000721371-19-000152","document":"wf-form4_157368004408825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/721371/000072137119000152/wf-form4_157368004408825.xml","form_type":"4"}},{"id":3379247,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-06T16:05:14.000Z","date":"2019-10-29","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the Company's 2008 Stock Incentive Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":25.89,"expiration_date":"2019-12-16","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001415889-19-001265","document":"form4-11062019_041101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001265/form4-11062019_041101.xml","form_type":"4"}},{"id":3379246,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-06T16:05:14.000Z","date":"2019-10-29","kind":"tax_withholding","acquired":false,"shares":3045,"price":106.3,"value":323683.5,"ownership":{"direct":true},"balance_after":39535,"source":{"system":"sec-edgar","filing":"0001415889-19-001265","document":"form4-11062019_041101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001265/form4-11062019_041101.xml","form_type":"4"}},{"id":3379245,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-06T16:05:14.000Z","date":"2019-10-29","kind":"exercise","acquired":true,"shares":12500,"price":25.89,"value":323625.0,"ownership":{"direct":true},"balance_after":42580,"source":{"system":"sec-edgar","filing":"0001415889-19-001265","document":"form4-11062019_041101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001265/form4-11062019_041101.xml","form_type":"4"}},{"id":3453439,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-30T20:02:39.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents shares of Company common stock underlying compensatory options to purchase shares of Company common stock, whether or not vested and which have a per share exercise price that is less than $48.00 (each, an \"In the Money Option\"). Pursuant to the terms of the Merger Agreement, each In the Money Option held by the Reporting Person was cancelled and converted into the right to a cash payment equal to (i) the excess, if any, of (A) $48.00 over (B) the exercise price payable per share of Company common stock under such In the Money Option, multiplied by (ii) the total number of shares of Company common stock subject to such In the Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option provided for vesting in four equal annual installments beginning on August 9, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option provided for vesting in four equal annual installments beginning on October 25, 2019."}],"balance_after":0,"derivative":{"exercise_price":14.55,"expiration_date":"2028-10-25","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-043777","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043777/doc4.xml","form_type":"4"}},{"id":3453438,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-30T20:02:39.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents shares of Company common stock underlying compensatory options to purchase shares of Company common stock, whether or not vested and which have a per share exercise price that is less than $48.00 (each, an \"In the Money Option\"). Pursuant to the terms of the Merger Agreement, each In the Money Option held by the Reporting Person was cancelled and converted into the right to a cash payment equal to (i) the excess, if any, of (A) $48.00 over (B) the exercise price payable per share of Company common stock under such In the Money Option, multiplied by (ii) the total number of shares of Company common stock subject to such In the Money Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option provided for vesting in four equal annual installments beginning on August 9, 2019."}],"balance_after":0,"derivative":{"exercise_price":14.93,"expiration_date":"2028-08-09","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-043777","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043777/doc4.xml","form_type":"4"}},{"id":3453437,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-30T20:02:39.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 14, 2019, Array BioPharma Inc. (the \"Company\") entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Pfizer Inc. (\"Pfizer\") and Arlington Acquisition Sub Inc., a wholly owned subsidiary of Pfizer (\"Purchaser\"). Pursuant to the terms of the Merger Agreement, each share of Company common stock held by the Reporting Person was cancelled and converted into the right to receive an amount in cash equal to $48.00, without interest and subject to any required withholding of taxes."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On July 30, 2019, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation and becoming a wholly-owned subsidiary of Pfizer. Pursuant to the terms of the Merger Agreement, each share of Company common stock was converted into the right to receive an amount in cash equal to $48.00, without interest and subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares of Company common stock underlying each restricted stock unit (a \"Company RSU\") held by the Reporting Person, whether or not vested. Pursuant to the terms of the Merger Agreement, each Company RSU held by the Reporting Person was converted into the right to receive an amount in cash equal to the product of (i) $48.00 and (ii) the number of shares of Company common stock subject to such Company RSU."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-19-043777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043777/doc4.xml","form_type":"4"}},{"id":3453436,"issuer":{"id":155788,"kind":"organization","name":"ARRAY BIOPHARMA INC","symbol":"ARRY"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-30T20:02:39.000Z","date":"2019-07-30","kind":"disposition_to_issuer","acquired":false,"shares":8000,"price":48,"value":384000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 14, 2019, Array BioPharma Inc. (the \"Company\") entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Pfizer Inc. (\"Pfizer\") and Arlington Acquisition Sub Inc., a wholly owned subsidiary of Pfizer (\"Purchaser\"). Pursuant to the terms of the Merger Agreement, each share of Company common stock held by the Reporting Person was cancelled and converted into the right to receive an amount in cash equal to $48.00, without interest and subject to any required withholding of taxes."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On July 30, 2019, Purchaser merged with and into the Company pursuant to Section 251(h) of the General Corporation Law of the State of Delaware, with the Company being the surviving corporation and becoming a wholly-owned subsidiary of Pfizer. Pursuant to the terms of the Merger Agreement, each share of Company common stock was converted into the right to receive an amount in cash equal to $48.00, without interest and subject to any required withholding of taxes."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-19-043777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100412/000120919119043777/doc4.xml","form_type":"4"}},{"id":3494604,"issuer":{"id":6900,"kind":"organization","name":"electroCore, Inc.","symbol":"ECOR"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2019-06-12T00:44:21.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":66964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Deferred Stock Units vest upon the close of business on the day before the next annual meeting of stockholders following the date hereof."}],"balance_after":66964,"derivative":{"exercise_price":0,"expiration_date":"2029-06-08","underlying":"Common Stock","underlying_shares":66964},"source":{"system":"sec-edgar","filing":"0000899243-19-016546","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000089924319016546/doc4.xml","form_type":"4"}},{"id":3499159,"issuer":{"id":6900,"kind":"organization","name":"electroCore, Inc.","symbol":"ECOR"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-07T00:13:16.000Z","date":"2019-06-06","kind":"purchase","acquired":true,"shares":10000,"price":1.82,"value":18200.0,"ownership":{"direct":true},"balance_after":21000,"source":{"system":"sec-edgar","filing":"0000899243-19-015903","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110753/000089924319015903/doc4.xml","form_type":"4"}},{"id":3501341,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-06-05T16:05:46.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":4756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest in three annual installments as follows: 1,585 shares on June 3, 2020; 1,585 shares on June 3, 2021; and 1,586 shares on June 3, 2022.  Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest in three annual installments as follows: 1,585 shares on June 3, 2020; 1,585 shares on June 3, 2021; and 1,586 shares on June 3, 2022.  Vested shares will be delivered to the reporting person promptly after the vesting date."}],"balance_after":4756,"derivative":{"underlying":"Common Stock","underlying_shares":4756},"source":{"system":"sec-edgar","filing":"0001415889-19-000667","document":"form4-06052019_040633.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000667/form4-06052019_040633.xml","form_type":"4"}},{"id":117249,"issuer":{"id":2834,"kind":"organization","name":"TEXAS INSTRUMENTS INC","symbol":"TXN"},"owners":[{"id":10815,"kind":"person","name":"COX CARRIE SMITH","position":1,"cik":"0001110753","reported_name":"COX CARRIE SMITH","relationship":{"director":true}}],"security":"NQ Stock Option (Right to Buy)","published_at":"2019-05-01T22:31:45.000Z","date":"2019-04-29","kind":"exercise","acquired":false,"shares":10002,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option became exercisable in four equal annual installments beginning on January 27, 2012."}],"balance_after":0,"derivative":{"exercise_price":34.63,"expiration_date":"2021-01-27","underlying":"Common Stock","underlying_shares":10002},"source":{"system":"sec-edgar","filing":"0001127602-19-016797","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/97476/000112760219016797/form4.xml","form_type":"4"}}],"next_cursor":"2019-05-01T22:31:45.000000Z,117249"}